Imprimis Pharmaceuticals Stock Forecast
Red day on Friday for Imprimis Pharmaceuticals
(Updated on May 03, 2024)
The Imprimis Pharmaceuticals stock price fell by -2.44% on the last day (Friday, 3rd May 2024) from $10.64 to $10.38. During the last trading day the stock fluctuated 6.98% from a day low at $10.21 to a day high of $10.92. The price has been going up and down for this period, and there has been a -0.67% loss for the last 2 weeks. Volume has increased on the last day by 78 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 271 thousand shares were bought and sold for approximately $2.82 million.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $10.07 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.48% during the next 3 months and, with a 90% probability hold a price between $10.62 and $14.49 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
HROW Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 3.80%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Imprimis Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.40 and $11.62. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for Imprimis Pharmaceuticals stock
Imprimis Pharmaceuticals finds support from accumulated volume at $10.32 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.713 between high and low, or 6.98%. For the last week, the stock has had daily average volatility of 5.14%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (HROW) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Imprimis Pharmaceuticals to open at $10.50, and during the day (based on 14 day Average True Range), to move between $9.75 and $11.01, which gives a possible trading interval of +/-$0.629 (+/-6.06%) up or down from last closing price. If Imprimis Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 12.12% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $10.32 (0.58%) than the resistance at $10.52 (1.35%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Imprimis Pharmaceuticals stock A Buy?
The Imprimis Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Imprimis Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score: -1.107 Sell Candidate Unchanged
Predicted Opening Price for Imprimis Pharmaceuticals of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $10.50 ( 1.20%) | $10.38 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for HROW
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 11.22 | 8.07 % | |
| R2 | 10.95 | 5.44 % | ||
| R1 | 10.78 | 3.82 % | ||
| Current price: | 10.38 | |||
| Support | S1 | 10.23 | -1.43 % | |
| S2 | 10.06 | -3.05 % | ||
| S3 | 9.79 | -5.67 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 11.50 | 10.79 % | |
| R2 | 10.58 | 1.93 % | ||
| R1 | 10.52 | 1.35 % | ||
| Current price | 10.38 | |||
| Support | S1 | 10.32 | -0.578% | |
| S2 | 10.00 | -3.66% | ||
| S3 | 9.95 | -4.14% |
FAQ
Click here for our free guide on how to buy Imprimis Pharmaceuticals Stock.
